Literature DB >> 21666210

Genetic characterization of measles vaccine strains.

Bettina Bankamp1, Makoto Takeda, Yan Zhang, Wenbo Xu, Paul A Rota.   

Abstract

The complete genomic sequences of 9 measles vaccine strains were compared with the sequence of the Edmonston wild-type virus. AIK-C, Moraten, Rubeovax, Schwarz, and Zagreb are vaccine strains of the Edmonston lineage, whereas CAM-70, Changchun-47, Leningrad-4 and Shanghai-191 were derived from 4 different wild-type isolates. Nucleotide substitutions were found in the noncoding regions of the genomes as well as in all coding regions, leading to deduced amino acid substitutions in all 8 viral proteins. Although the precise mechanisms involved in the attenuation of individual measles vaccines remain to be elucidated, in vitro assays of viral protein functions and recombinant viruses with defined genetic modifications have been used to characterize the differences between vaccine and wild-type strains. Although almost every protein contributes to an attenuated phenotype, substitutions affecting host cell tropism, virus assembly, and the ability to inhibit cellular antiviral defense mechanisms play an especially important role in attenuation. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2011.

Mesh:

Substances:

Year:  2011        PMID: 21666210     DOI: 10.1093/infdis/jir097

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Measles virus C protein interferes with Beta interferon transcription in the nucleus.

Authors:  Konstantin M J Sparrer; Christian K Pfaller; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Simultaneous Detection and Differentiation between Wild-Type and Vaccine Measles Viruses by a Multiplex Real-Time Reverse Transcription-PCR Assay.

Authors:  Kanti Pabbaraju; Kara Gill; Anita A Wong; Graham A Tipples; Joanne Hiebert; Alberto Severini; Kevin Fonseca; Raymond Tellier
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

3.  Vaccine-associated measles in a healthy 40-year-old woman.

Authors:  Lucas Churchill; Francesco A Rizzuti; Kevin Fonseca; Joseph Kim
Journal:  CMAJ       Date:  2018-09-04       Impact factor: 8.262

4.  Progress towards Rapid Detection of Measles Vaccine Strains: a Tool To Inform Public Health Interventions.

Authors:  Jill K Hacker
Journal:  J Clin Microbiol       Date:  2016-12-21       Impact factor: 5.948

Review 5.  Measles Vaccine.

Authors:  Diane E Griffin
Journal:  Viral Immunol       Date:  2017-12-19       Impact factor: 2.257

6.  Development of an epitope panel for consistent identification of antigen-specific T-cells in humans.

Authors:  Andreas Fløe; Caroline Løppke; Ole Hilberg; Christian Wejse; Liselotte Brix; Kivin Jacobsen
Journal:  Immunology       Date:  2017-07-03       Impact factor: 7.397

Review 7.  Oncolytic measles virus strains as novel anticancer agents.

Authors:  Pavlos Msaouel; Mateusz Opyrchal; Evidio Domingo Musibay; Evanthia Galanis
Journal:  Expert Opin Biol Ther       Date:  2013-01-06       Impact factor: 4.388

8.  Measles vaccine strain from the skin rash of a DiGeorge patient receiving tumor necrosis factor inhibitor.

Authors:  Pui-Ying Iroh Tam; Benjamin R Hanisch; Kate Klammer; Aaron S DeVries
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

9.  PACT- and RIG-I-Dependent Activation of Type I Interferon Production by a Defective Interfering RNA Derived from Measles Virus Vaccine.

Authors:  Ting-Hin Ho; Chun Kew; Pak-Yin Lui; Chi-Ping Chan; Takashi Satoh; Shizuo Akira; Dong-Yan Jin; Kin-Hang Kok
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

10.  Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.

Authors:  Charles T Spencer; Jelena S Bezbradica; Mireya G Ramos; Chenoa D Arico; Stephanie B Conant; Pavlo Gilchuk; Jennifer J Gray; Mu Zheng; Xinnan Niu; William Hildebrand; Andrew J Link; Sebastian Joyce
Journal:  Proteomics Clin Appl       Date:  2015-12       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.